Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-25

FDA Approved: SUMATRIPTAN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Sumatriptan submitted by Prasco Laboratories. This action yields a supplemental approval for the product, potentiall…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)